EUVIMEDEUVIMED entdecken
Crossref

Betaine Attenuates High‐Fat‐Diet‐Induced Metabolism‐Associated Steatotic Liver Disease via the Inhibition of Ferroptosis Through the Nrf2/GPX4 Axis

Xiao-Jun Zhai, Cheng Xiao, Chun-Ru Yang, Ze-Rui Ding, Dong-Mei Wang iD, Jie-Ying Liu iD, Yu Miao

The FASEB Journal · 31.12.2025 · 39 (24)

DOI: 10.1096/fj.202501416rrrr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 19.12.2025. Verfasst von Xiao-Jun Zhai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Beijing, China. Hauptthemen laut MEDLINE: Ferroptosis, Betaine, Diet, High-Fat, NF-E2-Related Factor 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Science and Technology Major Project (), National high level hospital clinical research fund, MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolism‐associated steatotic liver disease (MASLD) encompasses a broad spectrum of liver disorders characterized by systemic metabolic imbalance, and its prevalence is increasing. Current therapeutic strategies are limited, highlighting the need for novel interventions. Ferroptosis has emerged as a significant factor in MASLD pathogenesis, suggesting a potential target for therapeutic development. A MASLD model was established in mice via a high‐fat diet. The mice in the betaine‐supplemented group were fed a diet containing 0.3% (w/w) betaine from the start of the intervention. Metabolic indicators, liver histology, and ferroptosis markers, such as lipid peroxidation and iron homeostasis, were evaluated. In vitro, AML12 cells were cultured with palmitic acid to mimic a high‐fat environment, and the preventive effects of betaine on ferroptosis markers were assessed. To further validate the antiferroptotic actions of betaine, erastin was used in both in vivo and in vitro models. In this study, betaine attenuated HFD‐induced hepatic steatosis, effectively reducing lipid peroxidation and iron accumulation both in vivo and in vitro. Furthermore, betaine also counteracted erastin‐induced hepatocyte ferroptosis. Mechanistic investigations revealed the activation of the Nrf2/GPX4 axis by betaine, elucidating its antiferroptotic mechanism. This study provides preliminary evidence that, in an early‐stage, preventive murine model, betaine could ameliorate hepatic steatosis by limiting ferroptosis, in association with Nrf2 pathway activation. These findings suggest the ferroptosis–Nrf2 axis as a potential target for preventive strategies and warrant further evaluation in advanced disease models and clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisBetaineDiet, High-FatNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseFatty LiverNon-alcoholic Fatty Liver DiseaseAnimalsMiceMaleMice, Inbred C57BLLipid PeroxidationLiverIron

Stichwörter der Autor:innen

GPX4Nrf2SLC7A11betaineferroptosismetabolism‐associated steatotic liver disease

Substanzen

BetaineNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseNfe2l2 protein, mouseglutathione peroxidase 4, mouseIron

Autor:innen und Institutionen

  • Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Beijing, China.
  • Department of Anesthesiology, Ministry of Health, Peking Union Medical College Hospital, Beijing, China.
  • Department of Endocrinology, Genetics, Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Center for Biomarker Discovery and Validation, National Infrastructures for Translational Medicine (PUMCH), Institute of Clinical Medicine, Peking Union Medical College Hospital, Beijing, China.

ORCID-Profile: Dong-Mei Wang, Jie-Ying Liu

Förderung

  • National Science and Technology Major Project ()
  • National high level hospital clinical research fund
  • MOST | National Natural Science Foundation of China (NSFC)
  • BUCT | Fundamental Research Funds for the Central Universities of Beijing University of Chemical Technology (Fundamental Research Funds for the Central Univers…
  • Peking Union Medical College Hospital
  • Chinese Academy of Medical Sciences
  • Peking Union Medical College
  • National Natural Science Foundation of China

Zitieren

APA

Zhai, X. J., Xiao, C., Yang, C. R., Ding, Z. R., Wang, D. M., Liu, J. Y., & Miao, Y. (2025). Betaine Attenuates High‐Fat‐Diet‐Induced Metabolism‐Associated Steatotic Liver Disease via the Inhibition of Ferroptosis Through the Nrf2/GPX4 Axis. The FASEB Journal, 39(24). https://doi.org/10.1096/fj.202501416rrrr

Vancouver

Zhai XJ, Xiao C, Yang CR, Ding ZR, Wang DM, Liu JY, et al. Betaine Attenuates High‐Fat‐Diet‐Induced Metabolism‐Associated Steatotic Liver Disease via the Inhibition of Ferroptosis Through the Nrf2/GPX4 Axis. The FASEB Journal. 2025;39(24). doi:10.1096/fj.202501416rrrr

BibTeX
@article{Zhai2025,
  author = {Zhai, Xiao-Jun and Xiao, Cheng and Yang, Chun-Ru and Ding, Ze-Rui and Wang, Dong-Mei and Liu, Jie-Ying and Miao, Yu},
  title = {Betaine Attenuates High‐Fat‐Diet‐Induced Metabolism‐Associated Steatotic Liver Disease via the Inhibition of Ferroptosis Through the Nrf2/GPX4 Axis},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {24},
  doi = {10.1096/fj.202501416rrrr}
}
Kostenlos starten →